miR-199a-3p directly interacts with the 3′-UTR of mTOR and inhibits the mTOR pathway and restrains endometrial cancer cell proliferation (Wu et al., 2013) as well as increases the sensitivity of HCC cells to doxorubicin-induced apoptosis (Fornari et al., 2010). Here, MTOR is linked to endometrial cancer.